lower
respiratori
infect
remain
one
top
global
caus
death
emerg
new
diseas
continu
concern
first
two
decad
centuri
born
wit
emerg
newli
recogn
coronavirus
rapidli
spread
around
globe
includ
sever
acut
respiratori
syndrom
viru
sar
middl
eastern
respiratori
syndrom
viru
mer
also
experienc
emerg
novel
pandem
influenza
strain
caus
substanti
morbid
mortal
around
world
transit
season
strain
although
perhap
frequent
think
virus
discuss
emerg
respiratori
infect
bacteria
left
mix
wit
increas
number
infect
legionella
spp
sinc
organ
initi
discoveri
explor
basic
epidemiolog
clinic
present
histopatholog
clinic
laboratori
diagnosi
four
pathogen
emphas
theme
human
evolv
relationship
natur
environ
contribut
infecti
burden
histolog
alon
rare
diagnost
infect
crucial
better
understand
diseas
togeth
reli
diagnost
acumen
pathologist
identifi
clinicopatholog
featur
rais
suspicion
diseas
lead
earli
control
spread
popul
bryan
patholog
emerg
respiratori
infect
captur
public
scientificmed
commun
fascin
concern
sinc
time
pneumon
plagu
manifest
recent
popular
movi
depict
airborn
viru
outbreak
debat
potenti
respiratori
spread
ebola
viru
common
theme
emerg
infect
includ
zoonot
host
chang
human
behavior
includ
increas
intern
travel
andor
modif
physic
environ
sever
emerg
agent
may
exhibit
respiratori
involv
herein
focu
emerg
pathogen
primarili
involv
respiratori
system
focu
repres
agent
demonstr
rang
featur
emerg
diseas
sar
mer
pandem
influenza
legionella
spp
sever
acut
respiratori
viru
sar
rapidli
fatal
pulmonari
infect
caus
sar
coronaviru
sarscov
first
document
outbreak
occur
primarili
china
region
outbreak
north
america
europ
attribut
humantohuman
transmiss
infect
intern
travel
genet
character
suggest
introduct
human
popul
occur
civet
mammal
found
liveanim
market
china
total
case
countri
includ
fatal
identifi
cours
outbreak
case
fatal
rate
robust
intern
respons
cost
estim
billion
dollar
help
contain
outbreak
new
case
report
sinc
novemb
coloni
horsesho
bat
southwestern
china
harbor
genet
similar
coronaviru
identifi
rais
possibl
viru
origin
bat
spread
aforement
anim
market
sarscov
transmit
human
respiratori
droplet
close
interact
individu
act
socal
super
spreader
infect
patient
gener
present
symptom
day
infect
epidemiolog
studi
outbreak
identifi
disproportion
number
death
occur
elderli
immunosuppress
sever
diseas
limit
year
age
younger
symptom
gener
nonspecif
fever
myalgia
malais
among
common
laboratori
derang
includ
lymphopenia
thrombocytopenia
elev
creactiv
protein
elev
lactat
dehydrogenas
ldh
prognost
avail
histopatholog
data
sarscov
primarili
ascertain
autopsi
case
report
case
fatal
sar
gross
evalu
organ
found
edemat
heavi
lung
weigh
g
multipl
area
congest
fig
cut
section
demonstr
irregular
patchi
area
consolid
suspici
pneumonia
inspect
upper
respiratori
tract
demonstr
mucopurul
materi
histolog
present
pulmonari
sar
infect
nonspecif
depend
time
sinc
symptom
onset
earli
phase
diseas
day
commonli
associ
acut
diffus
alveolar
damag
later
phase
diseas
demonstr
combin
diffus
alveolar
damag
fig
acut
fibrin
organ
pneumonia
addit
featur
squamou
metaplasia
multinuclear
giant
cell
format
intravascular
microthrombi
may
appar
intracytoplasm
viral
inclus
also
describ
alveolar
epitheli
cell
fig
autopsi
case
sar
outbreak
reveal
correl
pattern
damag
clinic
signific
outcom
furthermor
pathognom
autopsi
featur
identifi
major
patient
specimen
taken
autopsi
littl
document
patholog
present
sarscov
live
patient
one
report
document
singl
open
lung
biopsi
taken
approxim
one
week
symptom
onset
patient
subsequ
diagnos
sar
patholog
find
includ
mild
increas
interstiti
lymphocyt
moder
increas
alveolar
macrophag
hyalin
membran
format
occasion
pneumocyt
demonstr
viral
cytopathiclik
chang
includ
cytomegali
nuclear
enlarg
promin
nucleoli
situ
hybrid
immunohistochem
stain
use
local
viral
element
within
tissu
samplespotenti
use
diagnost
studi
viral
tropism
studi
identifi
sarscov
lung
intestin
enterocyt
splenic
white
pulp
within
lung
immunofluoresc
situ
hybrid
studi
coloc
viral
rna
cellular
cytokeratin
suggest
infect
cell
pneumocyt
sarscov
may
occasion
identifi
within
pulmonari
macrophag
ultrastructur
studi
similarli
demonstr
sarscov
virion
nucleocapsid
inclus
within
pneumocyt
due
nonspecif
natur
sarscov
infect
rapid
spread
easili
implement
accur
diagnost
necessari
compon
diseas
control
test
detect
viral
rna
rtpcr
rapidli
develop
follow
initi
sar
outbreak
sensit
molecular
detect
affect
sampl
collect
site
time
sinc
infect
gener
blood
often
first
bodi
fluid
viral
rna
detect
patient
posit
day
symptom
onset
peak
valu
day
comparison
viral
rna
detect
respiratori
tract
sampl
first
four
day
peak
day
nasopharyng
swab
use
diagnost
serial
test
consid
minor
infect
patient
posit
time
present
viral
rna
also
detect
stool
sampl
day
postsymptom
onset
serologicallyconfirm
sar
patient
reason
multimod
approach
sampl
differ
bodi
fluid
variou
time
point
earli
infect
may
help
diseas
identif
high
pretest
probabl
clinic
sensit
rtpcr
test
may
affect
region
viru
target
initi
sar
pcr
assay
direct
toward
polymeras
gene
subsequ
vitro
data
demonstr
increas
sensit
target
nucleocapsid
gene
serolog
test
use
elisa
indirect
immunofluoresc
use
monitor
convalesc
patient
perform
serosurvey
major
infect
patient
seroconvert
igm
valu
peak
week
onset
symptom
remain
detect
week
postinfect
igg
valu
reach
peak
titer
slowli
may
persist
indefinetli
serolog
studi
use
rang
reagent
method
indirect
immunofluoresc
elisa
purifi
viru
recombin
nucleocapsid
protein
middl
east
respiratori
syndrom
mer
first
identifi
septemb
saudi
arabian
patient
respiratori
failur
comparison
rapid
spread
subsequ
quiescenc
sarscov
merscov
continu
circul
produc
sporad
outbreak
within
arabian
peninsula
countri
infect
patient
travel
confirm
case
mer
fatal
case
fatal
signific
molecular
serolog
data
point
dromedari
camel
sourc
transmiss
human
popul
whether
camel
intermedi
host
reservoir
still
research
studi
found
fragment
merscov
genom
materi
ident
human
isol
bat
popul
transmiss
camel
may
introduc
merscov
human
popul
major
report
case
result
humantohuman
nosocomi
transmiss
one
outbreak
singl
ill
patient
admit
korean
hospit
led
infect
includ
fatal
case
persontoperson
spread
also
document
within
household
patient
respiratori
secret
close
proxim
carri
highest
risk
tranmiss
reason
patient
symptom
epidemiolog
featur
suggest
mer
rapidli
quarantin
test
viral
infect
clinic
present
vari
asymptomat
infect
sever
diseas
gener
older
patient
chronic
comorbid
condit
diabet
heart
diseas
greatest
risk
progress
respiratori
failur
despit
high
mortal
associ
symptomat
case
studi
reveal
approxim
patient
asymptomat
infect
merscov
clinic
diseas
children
uncommon
seroepidemiolog
studi
patient
sampl
saudi
arabia
found
posit
antibodi
patient
camelexposur
higher
probabl
posit
serolog
may
serv
asymptomat
subclin
transmiss
sourc
clinic
symptom
nonspecif
includ
runni
nose
sore
throat
myalgia
incub
period
rang
day
symptom
appear
patient
reach
detect
viremia
addit
respiratori
symptom
gastrointestin
distress
neurolog
sequela
document
common
laboratori
derang
observ
leukopenia
thrombocytopenia
anemia
patholog
find
associ
human
merscov
infect
limit
due
rare
number
autopsi
perform
case
report
ng
et
al
man
die
day
admiss
due
respiratori
failur
shock
studi
includ
histolog
immunohistochemistri
multipl
merscov
antibodi
ultrastructur
evalu
primari
find
autopsi
viralmedi
lung
damag
featur
diffus
alveolar
damag
infect
cell
type
includ
pneumocyt
multinucl
epitheli
cell
bronchial
submucos
gland
infect
cell
express
surfac
antigen
serv
cell
receptor
merscov
sampl
posit
tissu
includ
lymphoreticular
system
kidney
gastrointestin
tract
brain
neg
viru
multipl
method
second
document
autopsi
patient
man
receiv
chemotherapi
tcell
lymphoma
receiv
antemortem
diagnosi
merscov
infect
sputum
pcr
caus
death
attribut
respiratori
renal
failur
autopsi
reveal
necrot
pneumonia
diffus
alveolar
damag
fig
partli
limit
possibl
confound
effect
therapi
tissu
sampl
limit
needl
core
biopsi
viral
inclus
identifi
electron
microscopi
respiratori
epithelium
also
epitheli
cell
renal
proxim
tubul
also
report
literatur
case
man
week
follow
infect
merscov
underw
renal
biopsi
histolog
demonstr
acut
tubular
sclerosi
proteinac
cast
format
acut
tubulointerstiti
nephriti
glomerulosclerosi
situ
hybrid
electron
microscopi
renal
tissu
neg
viral
compon
despit
pauciti
autopsi
case
multipl
studi
examin
pathogenesi
merscov
human
tissu
ex
vivo
anim
model
studi
compar
replic
camelisol
humanisol
merscov
strain
research
found
similar
replic
kinet
cellular
tropism
strain
infect
noncili
bronchial
epithelium
alveolar
epitheli
cell
includ
type
ii
pneumocyt
infect
pulmonari
macrophag
identifi
studi
kidney
explant
demonstr
infect
multipl
cell
type
includ
renal
tubular
cell
vascular
endotheli
cell
podocyt
experiment
infect
small
intestin
explant
merscov
demonstr
infect
limit
surfac
enterocyt
format
syncyti
cell
keep
observ
infect
patient
found
shed
viru
urin
stool
mous
model
express
human
receptor
rapidli
develop
discoveri
viru
model
use
understand
inflammatori
pattern
viral
local
identifi
evid
viru
lung
brain
heart
spleen
intestin
rhesu
macaqu
model
demonstr
similar
diseas
phenotyp
seen
human
includ
pulmonari
consolid
edemat
lung
lesion
pneumonia
also
frequent
observ
multinucl
giant
cell
acut
diffus
alveolar
damag
hyalin
membran
format
one
studi
infecti
viru
identifi
lung
upper
respiratori
track
blood
solid
organ
clinic
laboratori
diagnost
transmiss
event
rtpcr
serv
primari
clinic
laboratori
diagnost
test
import
success
test
understand
viral
kinet
tissu
tropism
found
merscov
case
sever
studi
document
lower
respiratori
tract
sampl
provid
highest
viral
load
viru
may
also
detect
upper
respiratori
swab
whole
blood
serum
fece
urin
despit
time
lower
viru
level
sampl
upper
respiratori
tract
blood
provid
addit
diagnost
util
provid
conveni
sampl
type
blood
posit
onehalf
onethird
case
detect
viremia
time
diagnosi
associ
increas
requir
mechan
ventil
patient
death
limit
viremia
rate
contrast
sarscov
rtpcr
blood
help
initi
diagnosi
often
first
posit
site
identifi
merscov
test
upper
lower
respiratori
sampl
along
patient
blood
may
help
maxim
sensit
also
stratifi
risk
two
rtpcr
test
strategi
grant
emerg
use
author
fda
target
region
upstream
envelop
gene
one
addit
target
region
gene
target
two
region
within
nucleocapsid
gene
serolog
merscov
infect
follow
similar
kinet
sarscov
major
patient
develop
detect
level
igm
igg
antibodi
week
follow
symptom
onset
case
detect
igm
add
diagnost
valu
compar
igg
serolog
test
use
diagnos
recent
infect
neutral
assay
increas
titer
day
use
confirm
specif
immun
respons
antibodi
respons
may
affect
diseas
sever
sever
studi
demonstr
pcrposit
patient
mild
diseas
often
produc
detect
level
antibodi
particularli
follow
past
acut
phase
diseas
etiolog
epidemiolog
clinic
present
contrast
emerg
mer
sar
influenza
pandem
reemerg
pathogen
commonli
respons
season
infect
demonstr
pandem
potenti
influenza
genom
contain
segment
capabl
antigen
drift
shift
drift
repres
small
nucleotid
mutat
shift
repres
exchang
genom
segment
larger
shift
central
pandem
potenti
viru
result
novel
antigen
previous
seen
human
popul
viru
first
emerg
mexico
spring
viru
contain
gene
segment
human
porcin
avian
influenza
strain
document
laboratoryconfirm
influenza
fatal
countri
outbreak
although
like
gross
underrepresent
cdc
estim
influenza
fatal
us
alon
estim
global
mortal
result
influenza
pandem
decreas
signific
contribut
factor
mortal
differ
thought
due
expand
medic
intervent
includ
improv
treatment
acut
respiratori
distress
secondari
bacteri
pneumonia
sinc
introduct
human
popul
strain
becom
commonli
circul
strain
incorpor
season
vaccin
full
clinic
spectrum
pandem
influenza
infect
differ
littl
season
influenza
howev
pandem
patient
infect
pandem
strain
younger
less
like
underli
condit
frequent
requir
ventilatori
support
icu
care
extrapulmonari
complic
younger
patient
also
higher
rate
advers
outcom
compar
season
case
major
infect
rang
subclin
signific
malais
fever
myalgia
rhinorrhea
case
progress
sever
diseas
acut
onset
hypoxemia
acut
respiratori
distress
frequent
addit
patient
sever
influenza
requir
hospit
increas
risk
develop
secondari
bacteri
pneumonia
acut
kidney
injuri
requir
mechan
ventil
prior
recent
pandem
influenza
outbreak
occur
broad
adopt
immunohistochem
molecular
techniqu
character
infecti
diseas
pandem
healthcar
research
expand
studi
viral
receptor
bind
replic
within
lower
respiratori
system
molecular
character
secondari
bacteri
pneumonia
autopsi
case
seri
multipl
countri
publish
use
varieti
techniqu
includ
ultrastructur
immunohistochem
situ
hybrid
molecular
method
vari
degre
gain
insight
patholog
pandem
influenza
infect
major
report
came
public
health
laboratori
vari
singl
case
report
cohort
fatal
case
gross
organ
find
infect
demonstr
edemat
heavi
lung
cut
section
frequent
reveal
thrombosi
small
pulmonari
vessel
area
consolid
suggest
bacteri
pneumonia
gross
organ
find
includ
cerebr
edema
hepat
congest
hemorrhag
necrosi
adren
gland
underli
condit
includ
obes
cardiovascular
diseas
asthma
pregnanc
common
fatal
case
microscop
acut
respiratori
distress
manifest
lung
diffus
alveolar
damag
intraalveolar
hyalin
membran
fig
variou
degre
organ
thrombot
pulmonari
vessel
addit
histolog
find
includ
bronchoalveolar
pneumonia
interstiti
septal
thicken
type
ii
pneumocyt
hyperplasia
less
frequent
observ
fibrosi
squamou
metaplasia
within
upper
respiratori
tract
tracheiti
bronchiti
rang
focal
sever
epithelium
frequent
ulcer
hemorrhag
submucos
gland
commonli
inflam
immunohistochem
stain
electron
microscopi
indic
viral
local
epithelium
fig
submucos
gland
pneumocyt
alveolar
macrophag
rare
endotheli
cell
nonrespiratori
tissu
extrapulmonari
manifest
influenza
observ
pandem
especi
neurolog
cardiac
dysfunct
describ
season
case
case
fatal
pandem
influenza
enceph
examin
brain
reveal
global
edema
tonsillar
herniat
punctat
hemorrhag
medulla
amyloid
precursor
protein
deposit
consist
pattern
ischem
injuri
seri
new
mexico
report
case
fulmin
pediatr
myocard
similarli
myocard
describ
fatal
pediatr
season
case
document
hepat
renal
chang
gener
nonspecif
anim
model
pandem
influenza
indic
better
replic
within
lower
respiratori
tract
higher
titer
viru
shed
compar
season
influenza
histopatholog
find
model
mimic
human
diseas
display
featur
necrot
bronchiol
alveolar
exud
antigen
posit
pneumocyt
nonhuman
primat
infect
pandem
influenza
sever
acut
cytopath
effect
within
bronchiol
alveoli
observ
compart
season
strain
within
lower
respiratori
tract
pandem
influenza
demonstr
similar
increas
virul
viral
titer
peak
higher
level
persist
longer
durat
addit
histopatholog
effect
caus
viral
infect
secondari
bacteri
infect
also
common
influenza
pandem
studi
estim
anywher
onequart
onehalf
patient
fatal
influenza
infect
coexist
bacteri
pneumonia
case
histolog
evid
acut
pneumonia
morpholog
confirm
bacteri
form
hematoxylin
eosin
special
stain
possibl
case
histolog
featur
often
observ
conjunct
bacteri
pneumonia
epitheli
necrosi
neutrophil
inflamm
find
bacteri
pneumonia
promin
later
stage
influenza
infect
case
bronchopneumonia
identifi
histolog
postmortem
cultur
pcr
identifi
bacteria
pandem
influenza
case
common
organ
identifi
patient
streptococcu
pneumonia
streptococcu
pyogen
less
common
pathogen
includ
streptococcu
miti
methicillinresist
staphylococcu
aureu
pseudomona
aeruginosa
clinic
laboratori
diagnost
patient
suspect
influenza
infect
diagnost
method
includ
viral
cultur
rapid
antigen
test
molecular
assay
major
clinic
diagnost
lab
shift
use
rapid
molecular
test
may
perform
laboratorydevelop
realtim
revers
transcript
pcr
rrtpcr
panel
cartridgebas
assay
method
demonstr
excel
analyt
paramet
turnaround
time
order
minut
hour
howev
shortcom
rapid
molecular
test
made
evid
pandem
primer
probe
set
design
around
recent
season
strain
influenza
b
novel
genet
element
pandem
strain
significantli
reduc
sensit
specif
test
fortun
molecular
assay
rapidli
adapt
detect
pandem
strain
rapid
antigen
test
alreadi
less
sensit
molecular
test
note
particularli
insensit
pandem
strain
clinic
laboratori
increas
suspicion
neg
result
novel
pathogen
outbreak
work
close
state
public
health
laboratori
valid
new
strain
test
regard
test
patient
influenzalik
ill
nasal
nasopharyng
swab
aspir
prefer
often
fdaclear
specimen
specimen
also
obtain
postmortem
autopsi
investig
epidemiolog
surveil
major
fatal
case
pandem
posit
nasopharyng
tracheal
swab
rrtpcr
greater
case
viral
nucleic
acid
present
formalin
fix
paraffin
embed
ffpe
tissu
shown
detect
stool
blood
urin
although
sampl
close
examin
pandem
autopsi
seri
legionella
spp
legionella
pneumophila
initi
recogn
agent
atyp
pneumonia
associ
namesak
legionnair
convent
philadelphia
legionella
speci
opportunist
pathogen
compris
divers
genu
speci
serogroup
roughli
onehalf
describ
associ
human
diseas
l
pneumophila
serogroup
commonli
associ
human
infect
although
serogroup
speci
togeth
caus
substanti
diseas
burden
legionella
also
caus
nonrespiratori
diseas
pontiac
fever
well
rare
wound
infect
organ
facult
intracellular
gramneg
rod
common
environ
natur
infect
sever
speci
freeliv
amoeba
process
parallel
infect
mammalian
macrophag
despit
highli
evolv
virul
trait
diseas
typic
occur
immunocompromis
patient
respiratori
compromis
host
amoeba
includ
soil
waterdwel
speci
human
infect
western
hemispher
known
sourc
attribut
inhal
water
humanengin
water
system
organ
like
concert
host
amoeba
colon
fresh
water
system
includ
air
condition
heatercool
potabl
water
system
etc
form
tenaci
biofilm
extrem
challeng
clear
shower
fountain
artifici
waterfal
similar
sourc
gener
aerosol
droplet
particular
risk
infect
nosocomi
communityacquir
one
case
possibl
humantohuman
transmiss
document
transmiss
natur
water
sourc
wide
recogn
diseas
thought
caus
communityacquir
pneumonia
legionella
nation
report
infect
demonstr
increas
case
approxim
report
case
although
figur
may
repres
actual
case
increas
case
entir
understood
may
repres
increas
report
chang
environment
factor
increas
host
suscept
infect
speci
l
pneumophila
caus
diseas
high
portion
patient
area
speci
often
underappreci
common
diagnost
test
detect
l
pneumophila
serogroup
mani
report
indic
legionella
micdadei
second
common
speci
caus
human
diseas
patient
symptomat
within
day
howev
incub
period
day
describ
complic
diagnosi
especi
earli
infect
rel
pauciti
respiratori
symptom
cough
present
frequent
nonproduct
fever
gastrointestin
symptom
bradycardia
alter
mental
statu
leukocytosi
hyponatremia
elev
transaminas
common
may
present
respiratori
symptom
presenc
extrapulmonari
find
rais
clinic
suspicion
diseas
compar
common
bacteri
pneumonia
radiolog
find
nonspecif
includ
progress
patchi
infiltr
consolid
pleural
effus
diseas
also
present
cavitari
lesion
especi
l
micdadei
one
seri
patient
cavitari
diseas
case
fatal
rate
highli
variabl
fatal
attribut
l
pneumophila
howev
death
l
micdadei
also
common
despit
demonstr
lower
virul
vitro
model
treatment
levofloxacin
azithromycin
empir
treatment
betalactam
delay
time
effect
therapi
consid
ineffect
similar
emerg
viral
respiratori
infect
clinic
radiolog
featur
legionella
speci
infect
pathognomon
histopatholog
featur
diagnost
legionella
infect
howev
appropri
clinicopatholog
context
presenc
sever
featur
rais
question
legionella
differenti
diagnosi
appropri
clinic
laboratori
test
consid
gross
find
includ
congest
firm
distend
lung
weigh
averag
g
diseas
present
unilater
bilater
commonli
lobular
confluent
lobular
pneumonia
cavit
nodul
abscess
empyema
may
present
particularli
l
micdadei
fig
microscop
find
includ
mark
fibrinopurul
exud
mix
necrot
infiltr
neutrophil
macrophag
complet
fill
alveolar
space
fig
compar
acut
bacteri
pneumonia
rel
abund
macrophag
organ
stain
weakli
gram
brown
hopp
fig
organ
evid
silver
stain
includ
warthinstarri
steiner
dieterl
organ
seen
intracellularli
within
macrophag
free
necrot
milieu
l
micdadei
speci
stain
use
microbiolog
histopatholog
modifi
acidfast
stain
fite
fig
lead
diagnost
misadventur
addit
mycobacteria
sever
parasit
hand
gramposit
organ
includ
nocardia
rhodococcu
tsukamurella
gordonia
dietzia
also
stain
modifi
acidfast
stain
contrast
l
micdadei
organ
stain
gram
posit
addit
nocardia
appear
branch
gram
posit
rod
help
differenti
l
micdadei
independ
posit
stain
fite
particularli
help
cultur
perform
molecular
studi
fail
amplifi
nucleic
acid
immunohistochem
stain
wide
avail
electron
microscopi
critic
earli
understand
infect
organ
life
cycl
play
role
routin
diagnosi
histopatholog
infecti
differenti
includ
influenza
nonnecrot
hemorrhag
bacteri
pneumonia
includ
klebsiella
pneumonia
haemophili
influenza
pneumonia
crucial
anatom
pathologist
understand
differ
clinic
laboratori
diagnost
legionella
speci
given
array
avail
test
limit
exampl
dilig
autopsi
pathologist
review
patient
chart
note
neg
lower
respiratori
cultur
urin
antigen
test
may
misl
away
diagnosi
legionella
infect
even
though
etiolog
could
still
legionella
sp
detect
method
gold
standard
clinic
laboratori
diagnost
cultur
legionella
spp
rel
slow
grow
vitro
typic
take
day
form
coloni
grow
routin
clinic
solid
media
agar
plate
supplement
activ
charcoal
requir
growth
ie
charcoalbuff
yeast
extract
bcye
limit
cumbersom
natur
cultur
mani
clinic
microbiolog
laboratori
perform
cultur
organ
even
special
media
may
includ
routin
lower
respiratori
cultur
wide
avail
use
urin
antigen
test
avail
fdaclear
simpl
later
flow
assay
high
sensit
specif
perform
within
min
critic
caveat
assay
detect
excret
antigen
l
pneumophila
serogroup
addit
caveat
includ
small
percent
patient
excret
antigen
frequent
antigen
detect
sever
week
infect
complic
interpret
timecours
infect
studi
vari
greatli
local
speci
serogroup
distribut
like
compon
actual
geograph
distribut
organ
report
bia
one
studi
half
sporad
case
year
period
due
speci
l
pneumophila
serogroup
cultur
addit
benefit
support
epidemiolog
investig
infect
control
yield
bacteri
isol
compar
environment
isol
hospit
water
sourc
humanengin
system
question
strain
type
assay
histor
perform
puls
field
gel
electrophoresi
sequencebas
type
limit
number
allel
contemporarili
perform
higher
degre
resolut
whole
genom
sequenc
wg
wg
commonli
perform
public
health
laboratori
outbreak
investig
also
avail
least
one
clia
laboratori
support
rapid
decis
make
hospit
infect
control
expert
molecular
diagnost
detect
l
pneumophila
direct
patient
specimen
also
avail
sever
clinic
laboratori
methodolog
target
sequenc
vari
frequent
employ
rtpcr
without
amplicon
sequenc
legionella
genusspecif
region
rrna
gene
rrna
mip
often
target
assay
vari
whether
detect
legionella
speci
l
pneumophila
limit
number
speci
although
molecular
assay
rapid
urin
antigen
test
expens
highli
sensit
perform
faster
cultur
distinct
advantag
detect
strain
l
pneumophila
serogroup
legionellaspecif
pcr
assay
avail
ffpe
sampl
although
limit
number
public
health
clia
refer
laboratori
avail
assay
ffpe
particularli
use
autopsi
pathologist
legionella
suspect
antemortem
broadrang
rrna
also
may
detect
organ
howev
frequent
reduc
sensit
compar
speciesspecif
assay
serolog
immunofluoresc
histor
role
limit
role
contemporari
clinic
diagnosi
organ
stain
poorli
safranin
gram
counter
stain
l
micdadei
modifi
acidfast
stain
posit
mafb
discuss
pathologist
essenti
compon
monitor
identifi
emerg
new
pathogen
classic
popul
concern
includ
immunocompromis
interfac
animalhuman
boundari
even
infecti
agent
well
known
lack
herd
immun
antigen
shift
wane
immun
vaccineprevent
diseas
voluntari
abstin
contribut
rapid
spread
diseas
within
human
popul
particularli
respiratori
infect
intern
travel
present
everincreas
risk
intern
air
transport
associ
report
record
billion
passeng
trip
role
histopatholog
outbreak
pandem
help
recogn
extent
respiratori
involv
well
extent
tissu
affect
although
mani
differ
infecti
agent
caus
similar
histopatholog
featur
featur
help
narrow
suffici
differenti
diagnosi
success
har
specif
molecular
method
hand
mani
molecular
laboratori
assay
target
specif
pathogen
assay
requir
intact
nucleic
acid
specimen
cultur
cast
broad
net
may
also
requir
specif
growth
condit
isol
microorgan
know
broad
array
differ
diagnost
method
paramount
identifi
emerg
reemerg
pathogen
